Tony Fraser’s Post

Is AI's role in drug development overhyped or underestimated? 2024 is set to be the year of the AI revolution in pharmaceuticals, but is the impact truly as groundbreaking as it's made out to be? The controversy surrounding AI's role in drug development revolves around the extent of its impact. Some argue that AI's potential is overhyped, leading to inflated expectations, while others believe its true implications are underestimated. This debate raises questions about the actual effectiveness of AI in reshaping the pharmaceutical landscape and its ability to deliver on the promises of efficiency and innovation. As AI continues to gain prominence in healthcare, understanding the real implications of its integration into drug development becomes crucial for shaping the future of the industry. We'd love to hear your thoughts on this debate. #AI #Pharma #artificialintelligence

Identifying and accelerating drug development is big business. The costs in this industry are significant and finding pathways to optimize using AI methods is top of mind in this fast and evolving industry. Deloitte found that the average cost of developing a new drug among the top 20 global #biopharmas it studied rose 15% ($298 million) last year, to approximately $2.3 billion. That figure includes the average cost of developing a candidate from discovery through clinical trials to the market. Many #biopharmaceutical companies are using #AI to speed up drug development. For example, machine-learning models are trained using information about the protein or #amino-acid sequence or 3D structure of previous drug candidates, and about properties of interest. https://lnkd.in/g3xQ8gkv

The potential benefits of generative AI in drug discovery are substantial, but careful consideration of data quality and regulatory frameworks is essential for its successful integration into the pharmaceutical industry. #GenerativeAI #DrugDiscovery #HealthcareInnovation 💊🧠🚀

Maulik Mukeshbhai Patel, a leading biopharmaceutical expert, recently highlighted, "The future is already here — it's just not evenly distributed." This insight captures AI's transformative impact on the pharmaceutical industry. Traditionally, drug development is slow and costly, but AI promises to speed up discovery and reduce costs. In his article, "Unveiling the Future of Life Sciences: Advances in Cell and Molecular Biology and the Role of AI in Drug Discovery," Patel shows how AI is revolutionizing drug development by cutting time and effort, benefiting patients with faster delivery of new therapies. While challenges like data biases and high initial costs remain, Patel remains optimistic. He envisions AI-driven innovations leading to safer, more effective, and accessible treatments. The future of medicine is here, and AI is at the forefront of this exciting transformation. Read more below on Patel’s AI-powered discoveries. https://lnkd.in/er9Q3R4F #MetricBio #AI #DrugDevelopment #Pharmaceuticals #Innovation #FutureOfMedicine #Healthcare 

Generative AI in the pharmaceutical industry: Moving from hype to reality --Accelerated drug discovery.  --More efficient clinical trials. --Quicker regulatory approvals. --Ultratargeted marketing and medical materials generated in-house. Generative AI has potential to transform nearly all aspects of the pharmaceutical industry, revamping the way companies operate and potentially unlocking billions of dollars in value. The McKinsey Global Institute (MGI) has estimated that the technology could generate $60 billion to $110 billion a year in economic value for the pharma and medical-product industries, largely because it can boost productivity by accelerating the process of identifying compounds for possible new drugs, speeding their development and approval, and improving the way they are marketed. #GenAI could offer #pharma companies a once-in-a-century opportunity but only if they learn to scale it and address the industry’s unique challenges, write my McKinsey & Company colleagues Chaitanya Adabala Viswa, Joachim Bleys, Eoin Leydon, Bhavik Shah and Delphine Nain Zurkiya, in a new 'Insights to Impact' article. Free to read, download and share https://lnkd.in/g2fAdrQ2

Harnessing AI's power to revolutionize drug development. Capturing the potential of genomics and AI in pharmaceuticals. #GenAIDrugDevelopment #AIinPharma #BiotechInnovation #GenomicsResearch #FutureOfMedicine #Femtosoftitservices https://lnkd.in/dcgVmKpz

💡 AI is transforming drug development – but not without challenges. From accelerating drug discovery to personalized medicine, AI holds immense potential for the pharmaceutical industry. Yet, issues like data quality, regulatory hurdles, and integration into existing workflows remain barriers to widespread adoption. 🌐 In our latest blog post, I explore both the opportunities and challenges of AI-driven drug development and how the industry can overcome them. The future of healthcare is being shaped by this emerging technology. Read more: https://lnkd.in/e9rW-xhj #AI #DrugDevelopment #PharmaInnovation #ClinicalTrials #MachineLearning #HealthcareTransformation #PharmaTech #Biotech

Formation Bio raises $372M to boost drug development with AI. Using #AI in pharmaceutical development could lead to cost savings for consumers. #OpenAI and #Sanofi are collaborating to design AI solutions for drug development. OpenAI will provide access to AI capabilities and expertise, while Sanofi will contribute proprietary data for AI model development. Interesting read.

AI is revolutionizing drug development in the biopharmaceutical industry! With drug development costs soaring to an average of $2.3 billion, AI is the beacon of hope for efficiency and innovation. 🚀💡 AI is slashing the time for new drug screening by 40-50%, significantly reducing the financial burden. Companies like BioPhy are helping lead the charge, leveraging AI to streamline processes and enhance decision-making. CEO Dr. Dave Latshaw shares his journey and the critical role of interdisciplinary collaboration in AI development. 📈🤝 AI’s prowess extends to ensuring adherence to complex regulations, mitigating risks, and expediting approvals. Whether you’re an innovator or a practitioner, AI offers diverse and impactful career opportunities in drug development. Check out the Forbes article linked to learn more about how AI is modernizing drug development. #biotech2024 #healthequity #artificialintelligence #innovation #healthcare #biotechinnovation #healthcaretrends #pharmaleaders #medicaladvancements #drugdevelopment #biopharma #lifesciences #patientcare #biotechresearch #therapeuticbreakthroughs #healthtech #healthtechinnovation #aiinhealthcare

Check out this article by McKinsey & Company to learn how Generative AI is moving from hype to reality in the pharmaceutical industry. The potential for #AI to revolutionize drug discovery and development is important, and is already transforming the industry. #innovation #futureofmedicine #genAi #AIpharma https://lnkd.in/dnUU68ZG